The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
Open accessAbstract
Background: Non-alcoholic fatty liver disease (NAFLD), characterized as excess lipid accumulation in the liver which is not due to alcohol use, has emerged as one of the major health problems around the world. The dysregulated lipid metabolism creates a lipotoxic environment which promotes the development of NAFLD, especially the progression from simple steatosis (NAFL) to non-alcoholic steatohepatitis (NASH). Purposeand Aim: This review focuses on the mechanisms of lipid accumulation in the liver, with an emphasis on the metabolic fate of free fatty acids (FFAs) in NAFLD and presents an update on the relevant cellular processes/mechanisms that are involved in lipotoxicity. The changes in the levels of various lipid species that result from the imbalance between lipolysis/lipid uptake/lipogenesis and lipid oxidation/secretion can cause organellar dysfunction, e.g. ER stress, mitochondrial dysfunction, lysosomal dysfunction, JNK activation, secretion of extracellular vesicles (EVs) and aggravate (or be exacerbated by) hypoxia which ultimately lead to cell death. The aim of this review is to provide an overview of how abnormal lipid metabolism leads to lipotoxicity and the cellular mechanisms of lipotoxicity in the context of NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of NAFLD development and therapeutic strategies
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Ekstedt, M., Hagström, H., Nasr, P., Fredrikson, M., Stål, P., Kechagias, S., & Hultcrantz, R. (2015) · Hepatology · doi:10.1002/hep.27368 · Cited by 2,287
Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets
Furuhashi, M., & Hotamisligil, G. S. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2589 · Cited by 1,785
A lipidomic analysis of nonalcoholic fatty liver disease
Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338
Dietary lipids, gut microbiota and lipid metabolism
Schoeler, M., & Caesar, R. (2019) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09512-0 · Cited by 1,163
Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease
Lebeaupin, C., Vallée, D., Hazari, Y., Hetz, C., Chevet, E., & Bailly-Maitre, B. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.06.008 · Cited by 944
Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
Jensen, T., Abdelmalek, M. F., Sullivan, S., Nadeau, K. J., Green, M., Roncal, C., Nakagawa, T., Kuwabara, M., Sato, Y., Kang, D.-H., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.01.019 · Cited by 941
Feldstein, A. E., Werneburg, N. W., Canbay, A., Guicciardi, M. E., Bronk, S. F., Rydzewski, R., Burgart, L. J., & Gores, G. J. (2004) · Hepatology · doi:10.1002/hep.20283 · Cited by 834
Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases
Mansouri, A., Gattolliat, C.-H., & Asselah, T. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.06.083 · Cited by 812
Sunny, N. E., Parks, E. J., Browning, J. D., & Burgess, S. C. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.11.004 · Cited by 672
The plasma lipidomic signature of nonalcoholic steatohepatitis
Puri, P., Wiest, M. M., Cheung, O., Mirshahi, F., Sargeant, C., Min, H., Contos, M. J., Sterling, R. K., Fuchs, M., Zhou, H., et al. (2009) · Hepatology · doi:10.1002/hep.23229 · Cited by 655
Csak, T., Ganz, M., Pespisa, J., Kodys, K., Dolganiuc, A., & Szabo, G. (2011) · Hepatology · doi:10.1002/hep.24341 · Cited by 645
The role of ER stress in lipid metabolism and lipotoxicity
Han, J., & Kaufman, R. J. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r067595 · Cited by 645
Fabbrini, E., Mohammed, B. S., Magkos, F., Korenblat, K. M., Patterson, B. W., & Klein, S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.038 · Cited by 631
González-Rodríguez, Á., Mayoral, R., Agra, N., Valdecantos, M. P., Pardo, V, Miquilena-Colina, M. E., Vargas-Castrillón, J., Lo Iacono, O., Corazzari, M., Fimia, G. M., et al. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.162 · Cited by 615
Apoptosis and necroptosis in the liver: a matter of life and death
Schwabe, R. F., & Luedde, T. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0065-y · Cited by 582
Recent insights into the pathogenesis of nonalcoholic fatty liver disease
Arab, J. P., Arrese, M., & Trauner, M. (2018) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043617 · Cited by 573
Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
Mota, M., Banini, B. A., Cazanave, S. C., & Sanyal, A. J. (2016) · Metabolism · doi:10.1016/j.metabol.2016.02.014 · Cited by 570
Cytosolic lipolysis and lipophagy: two sides of the same coin
Zechner, R., Madeo, F., & Kratky, D. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.76 · Cited by 550
Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease
Khan, R. S., Bril, F., Cusi, K., & Newsome, P. N. (2019) · Hepatology · doi:10.1002/hep.30429 · Cited by 542
Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes
Hirsova, P., Ibrahim, S. H., Krishnan, A., Verma, V. K., Bronk, S. F., Werneburg, N. W., Charlton, M. R., Shah, V. H., Malhi, H., & Gores, G. J. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.12.037 · Cited by 507
Wilson, C. G., Tran, J. L., Erion, D. M., Vera, N. B., Febbraio, M., & Weiss, E. J. (2016) · Endocrinology · doi:10.1210/en.2015-1866 · Cited by 463
Younossi, Z. M., Marchesini, G., Pinto-Cortez, H., & Petta, S. (2019) · Transplantation · doi:10.1097/tp.0000000000002484 · Cited by 404
Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus
Targher, G., Lonardo, A., & Byrne, C. D. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.173 · Cited by 397
Autophagy in liver diseases: Time for translation?
Allaire, M., Rautou, P.-E., Codogno, P., & Lotersztajn, S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.01.026 · Cited by 378
Biomarkers of NAFLD progression: a lipidomics approach to an epidemic
Gorden, D. L., Myers, D. S., Ivanova, P. T., Fahy, E., Maurya, M. R., Gupta, S., Min, J., Spann, N. J., McDonald, J. G., Kelly, S. L., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.p056002 · Cited by 372
Pirola, C. J., Gianotti, T. F., Burgueño, A. L., Rey-Funes, M., Loidl, C. F., Mallardi, P., Martino, J. S., Castaño, G. O., & Sookoian, S. (2013) · Gut · doi:10.1136/gutjnl-2012-302962 · Cited by 364
Calcium Homeostasis and Organelle Function in the Pathogenesis of Obesity and Diabetes
Arruda, A. P., & Hotamisligil, G. S. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.06.010 · Cited by 341
Musso, G., Cassader, M., Paschetta, E., & Gambino, R. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.06.031 · Cited by 332
Luedde, M., Lutz, M., Carter, N., Sosna, J., Jacoby, C., Vucur, M., Gautheron, J., Roderburg, C., Borg, N., Reisinger, F., et al. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu146 · Cited by 315
The lysosomal-mitochondrial axis in free fatty acid–induced hepatic lipotoxicity
Li, Z., Berk, M., McIntyre, T. M., Gores, G. J., & Feldstein, A. E. (2008) · Hepatology · doi:10.1002/hep.22183 · Cited by 289
Kakazu, E., Mauer, A. S., Yin, M., & Malhi, H. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m063412 · Cited by 280
Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis
Hirsova, P., Ibrabim, S. H., Gores, G. J., & Malhi, H. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r066357 · Cited by 270
Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver Disease
Mesarwi, O. A., Loomba, R., & Malhotra, A. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201806-1109tr · Cited by 263
Chiappini, F., Coilly, A., Kadar, H., Gual, P., Tran, A., Desterke, C., Samuel, D., Duclos-Vallée, J.-C., Touboul, D., Bertrand-Michel, J., et al. (2017) · Scientific Reports · doi:10.1038/srep46658 · Cited by 246
Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes
Cholankeril, G., Wong, R. J., Hu, M., Perumpail, R. B., Yoo, E. R., Puri, P., Younossi, Z. M., Harrison, S. A., & Ahmed, A. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4684-x · Cited by 234
Lee, Y.-S., Kim, S. Y., Ko, E., Lee, J.-H., Yi, H.-S., Yoo, Y. J., Je, J., Suh, S. J., Jung, Y. K., Kim, J. H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03389-2 · Cited by 233
Ibrahim, S. H., Hirsova, P., Tomita, K., Bronk, S. F., Werneburg, N. W., Harrison, S. A., Goodfellow, V. S., Malhi, H., & Gores, G. J. (2016) · Hepatology · doi:10.1002/hep.28252 · Cited by 232
Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation
Fon Tacer, K., & Rozman, D. (2011) · Journal of Lipids · doi:10.1155/2011/783976 · Cited by 231
Microbiota and Fatty Liver Disease—the Known, the Unknown, and the Future
Lang, S., & Schnabl, B. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.07.007 · Cited by 231
Lytic cell death in metabolic liver disease
Gautheron, J., Gores, G. J., & Rodrigues, C. M. P. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.001 · Cited by 225
Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance†
Singh, R., Wang, Y., Xiang, Y., Tanaka, K. E., Gaarde, W. A., & Czaja, M. J. (2009) · Hepatology · doi:10.1002/hep.22578 · Cited by 223
Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis
Kakisaka, K., Cazanave, S. C., Fingas, C. D., Guicciardi, M. E., Bronk, S. F., Werneburg, N. W., Mott, J. L., & Gores, G. J. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00301.2011 · Cited by 222
Afonso, M. B., Rodrigues, P. M., Carvalho, T., Caridade, M., Borralho, P., Cortez-Pinto, H., Castro, R. E., & Rodrigues, C. M. P. (2015) · Clinical Science · doi:10.1042/cs20140732 · Cited by 221
Lipid signaling in adipose tissue: Connecting inflammation & metabolism
Masoodi, M., Kuda, O., Rossmeisl, M., Flachs, P., & Kopecky, J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.09.023 · Cited by 221
Peng, K.-Y., Watt, M. J., Rensen, S., Greve, J. W., Huynh, K., Jayawardana, K. S., Meikle, P. J., & Meex, R. C. R. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m085613 · Cited by 220
Death Receptor-Mediated Cell Death and Proinflammatory Signaling in Nonalcoholic Steatohepatitis
Hirsova, P., & Gores, G. J. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2014.11.005 · Cited by 197
Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones
Geisler, C. E., & Renquist, B. J. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0513 · Cited by 191
Jo, H., Choe, S. S., Shin, K. C., Jang, H., Lee, J. H., Seong, J. K., Back, S. H., & Kim, J. B. (2013) · Hepatology · doi:10.1002/hep.26126 · Cited by 189
SIRT3 promotes lipophagy and chaperon-mediated autophagy to protect hepatocytes against lipotoxicity
Zhang, T., Liu, J., Shen, S., Tong, Q., Ma, X., & Lin, L. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0356-z · Cited by 184
Win, S., Than, T. A., Zhang, J., Oo, C., Min, R. W. M., & Kaplowitz, N. (2018) · Hepatology · doi:10.1002/hep.29689 · Cited by 171
Chen, X., Li, L., Liu, X., Luo, R., Liao, G., Li, L., Liu, J., Cheng, J., Lu, Y., & Chen, Y. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.04.022 · Cited by 169
Zhou, Y., Orešič, M., Leivonen, M., Gopalacharyulu, P. V., Hyysalo, J., Arola, J. T., Verrijken, A., Francque, S., Gaal, L. V., Hyötyläinen, T., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.05.046 · Cited by 168
Zhang, N., Liu, X., Xie, L. H., Shen, X., & Wu, J. (2019) · Laboratory Investigation · doi:10.1038/s41374-018-0177-6 · Cited by 166
Egnatchik, R. A., Leamy, A. K., Noguchi, Y., Shiota, M., & Young, J. D. (2014) · Metabolism · doi:10.1016/j.metabol.2013.10.009 · Cited by 161
Metabolic Targets in Nonalcoholic Fatty Liver Disease
Esler, W. P., & Bence, K. K. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.04.007 · Cited by 158
Majdi, A., Aoudjehane, L., Ratziu, V., Islam, T., Afonso, M. B., Conti, F., Mestiri, T., Lagouge, M., Foufelle, F., Ballenghien, F., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.11.008 · Cited by 156
Receptor interacting protein 3 protects mice from high‐fat diet‐induced liver injury
Roychowdhury, S., McCullough, R. L., Sanz‐García, C., Saikia, P., Alkhouri, N., Matloob, A., Pollard, K. A., McMullen, M. R., Croniger, C. M., & Nagy, L. E. (2016) · Hepatology · doi:10.1002/hep.28676 · Cited by 155
The Role of Lipid and Lipoprotein Metabolism in Non‐Alcoholic Fatty Liver Disease
Perla, F. M., Prelati, M., Lavorato, M., Visicchio, D., & Anania, C. (2017) · Children · doi:10.3390/children4060046 · Cited by 147
Chan, J. Y., Luzuriaga, J., Maxwell, E. L., West, P. K., Bensellam, M., & Laybutt, D. R. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.06.025 · Cited by 142
Chen, X., Zhang, F., Gong, Q., Cui, A., Zhuo, S., Hu, Z., Han, Y., Gao, J., Sun, Y., Liu, Z., et al. (2016) · Diabetes · doi:10.2337/db15-1637 · Cited by 139
Cunha, D. A., Igoillo-Esteve, M., Gurzov, E. N., Germano, C. M., Naamane, N., Marhfour, I., Fukaya, M., Vanderwinden, J.-M., Gysemans, C., Mathieu, C., et al. (2012) · Diabetes · doi:10.2337/db12-0123 · Cited by 130
The roles of c‐Jun NH2‐terminal kinases (JNKs) in obesity and insulin resistance
Pál, M., Febbraio, M. A., & Lancaster, G. I. (2015) · The Journal of Physiology · doi:10.1113/jp271457 · Cited by 127
Bailly‐Maitre, B., Belgardt, B., Jordan, S. D., Coornaert, B., von Freyend, M. J., Kleinridders, A., Mauer, J., Cuddy, M., Kress, C. L., Willmes, D. M., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.056648 · Cited by 124
Achard, C. S., & Laybutt, D. R. (2012) · Endocrinology · doi:10.1210/en.2011-1881 · Cited by 114
Machado, M. V., Michelotti, G. A., Pereira, T. A., Boursier, J., Krüger, L., Swiderska‐Syn, M., Karaca, G., Xie, G., Guy, C. D., Bohinc, B. N., et al. (2014) · Gut · doi:10.1136/gutjnl-2014-307362 · Cited by 110
Moreno-Fernandez, M. E., Giles, D. A., Stankiewicz, T. E., Sheridan, R., Karns, R., Cappelletti, M., Lampe, K., Mukherjee, R., Sina, C., Sallese, A., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.93626 · Cited by 106
Questions and controversies: the role of necroptosis in liver disease
Dara, L., Liu, Z., & Kaplowitz, N. (2016) · Cell Death Discovery · doi:10.1038/cddiscovery.2016.89 · Cited by 106
van den Berg, E. H., Amini, M., Schreuder, T. C. M. A., Dullaart, R. P. F., Faber, K. N., Alizadeh, B. Z., & Blokzijl, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171502 · Cited by 106
Self-citationNonalcoholic fatty liver disease in chronic obstructive pulmonary disease
Viglino, D., Jullian‐Desayes, I., Minovès, M., Aron‐Wisnewsky, J., Leroy, V., Zarski, J., Tamisier, R., Joyeux‐Faure, M., & Pépin, J. (2017) · European Respiratory Journal · doi:10.1183/13993003.01923-2016 · Cited by 104
TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess
Idrissova, L., Malhi, H., Werneburg, N. W., LeBrasseur, N. K., Bronk, S. F., Fingas, C. D., Tchkonia, T., Pirtskhalava, T., White, T. A., Stout, M. B., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.033 · Cited by 103
Morello, E., Sutti, S., Foglia, B., Novo, E., Cannito, S., Bocca, C., Rajsky, M., Bruzzì, S., Abate, M. L., Rosso, C., et al. (2017) · Hepatology · doi:10.1002/hep.29754 · Cited by 103
Pyroptosis: An Inflammatory Link Between NAFLD and NASH With Potential Therapeutic Implications
Beier, J. I., & Banales, J. M. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.01.017 · Cited by 101
Tiwari-Heckler, S., Gan-Schreier, H., Stremmel, W., Chamulitrat, W., & Pathil, A. (2018) · Nutrients · doi:10.3390/nu10050649 · Cited by 96
Cabrera, D., Wree, A., Povero, D., Solís, N., Hernández, A., Pizarro, M., Moshage, H. J., Torres, J., Feldstein, A. E., Cabello‐Verrugio, C., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03675-z · Cited by 96
Self-citationPetersen, K. F., Befroy, D. E., Dufour, S., Rothman, D. L., & Shulman, G. I. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.005 · Cited by 93
Miyagawa, K., Oe, S., Honma, Y., Izumi, H., Baba, R., & Harada, M. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.03.003 · Cited by 91
Caspases in metabolic disease and their therapeutic potential
Wilson, C. H., & Kumar, S. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0111-x · Cited by 89
Bédossa, P., Tordjman, J., Aron‐Wisnewsky, J., Poitou, C., Oppert, J., Torcivia, A., Bouillot, J., Paradis, V., Ratziu, V., & Clément, K. (2016) · Gut · doi:10.1136/gutjnl-2016-312238 · Cited by 87
Sundaram, S. S., Halbower, A. C., Pan, Z., Robbins, K. N., Capocelli, K. E., Klawitter, J., Shearn, C. T., & Sokol, R. J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.010 · Cited by 85
Wang, X., Zhang, X., Chu, E. S., Chen, X., Kang, W., Wu, F., To, K., Wong, V. W., Chan, H. L., Chan, M. T. V., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201601393r · Cited by 82
Vadarlis, A., Antza, C., Bakaloudi, D. R., Doundoulakis, I., Kalopitas, G., Samara, M. T., Dardavesis, T. I., Maris, T., & Chourdakis, M. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15221 · Cited by 82
Protective effect of metformin against palmitate-induced hepatic cell death
Geng, Y., Villanueva, A. H., Oun, A., Buist‐Homan, M., Blokzijl, H., Faber, K. N., Dolga, A. M., & Moshage, H. J. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165621 · Cited by 76
Self-citationReduced Lysosomal Acid Lipase Activity in Adult Patients With Non-alcoholic Fatty Liver Disease
Baratta, F., Pastori, D., Ben, M. D., Polimeni, L., Labbadia, G., Santo, S. D., Piemonte, F., Tozzi, G., Violi, F., & Angelico, F. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.05.018 · Cited by 73
Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy
Hernández, A., Arab, J. P., Reyes, D., Lapitz, A., Moshage, H. J., Bañales, J. M., & Arrese, M. A. (2020) · Cells · doi:10.3390/cells9040817 · Cited by 73
Self-citationMitochondrial adaptation in steatotic mice
Einer, C., Hohenester, S., Wimmer, R., Wottke, L., Artmann, R., Schulz, S., Gosmann, C., Simmons, A., Leitzinger, C., Eberhagen, C., et al. (2018) · Mitochondrion · doi:10.1016/j.mito.2017.08.015 · Cited by 72
Hernández, A., Geng, Y., Sepúlveda, R., Solís, N., Torres, J., Arab, J. P., Francisco Barrera, M., Cabrera, D., Moshage, H. J., & Arrese, M. A. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165753 · Cited by 72
Self-citationA hedgehog survival pathway in ‘undead’ lipotoxic hepatocytes
Kakisaka, K., Cazanave, S. C., Werneburg, N. W., Razumilava, N., Mertens, J. C., Bronk, S. F., & Gores, G. J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.05.011 · Cited by 71
Lipid mediators of liver injury in nonalcoholic fatty liver disease
Liangpunsakul, S., & Chalasani, N. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00170.2018 · Cited by 68
Caspase-2 promotes obesity, the metabolic syndrome and nonalcoholic fatty liver disease
Machado, M. V., Michelotti, G. A., Jewell, M. L., Pereira, T. A., Xie, G., Premont, R. T., & Diehl, A. M. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.19 · Cited by 63
Enooku, K., Tsutsumi, T., Kondo, M., Fujiwara, N., Sasako, T., Shibahara, J., Kado, A., Okushin, K., Fujinaga, H., Nakagomi, R., et al. (2019) · Journal of Gastroenterology · doi:10.1007/s00535-019-01633-2 · Cited by 60
Teratani, T., Tomita, K., Furuhashi, H., Sugihara, N., Higashiyama, M., Nishikawa, M., Irie, R., Takajo, T., Wada, A., Horiuchi, K., et al. (2019) · Hepatology Communications · doi:10.1002/hep4.1383 · Cited by 56
López‐Domènech, S., Abad‐Jiménez, Z., Iannantuoni, F., Marañón, A., Rovira‐Llopis, S., Morillas, C., Bañuls, C., Víctor, V. M., & Rocha, M. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.10.005 · Cited by 54
Arai, T., Tanaka, M., & Goda, N. (2018) · Scientific Reports · doi:10.1038/s41598-018-32586-w · Cited by 51
Weng, H., Ji, X., Naito, Y., Endo, K., Ma, X., Takahashi, R., Shen, C.-S., Hirokawa, G., Fukushima, Y., & Iwai, N. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00425.2012 · Cited by 50
Calcium Signaling As a Therapeutic Target for Liver Steatosis
Ali, E. S., & Petrovsky, N. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.02.005 · Cited by 50
Hepatic lipase activity is increased in non‐alcoholic fatty liver disease beyond insulin resistance
Miksztowicz, V., Lucero, D., Zago, V., Cacciagiú, L. D., López, G., Ballerga, E. G., Sorda, J. A., Fassio, E., Schreier, L. E., & Berg, G. A. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2312 · Cited by 49
Physiological Mechanisms of Weight Gain−Induced Steatosis in People With Obesity
Fabbrini, E., Luecking, C. T., Love-Gregory, L. D., Okunade, A. L., Yoshino, M., Fraterrigo, G., Patterson, B. W., & Klein, S. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.09.003 · Cited by 49
Caveolin1 protects against diet induced hepatic lipid accumulation in mice
Li, M., Chen, D., Huang, H., Wang, J., Wan, X., Xu, C., Li, C., Ma, H., Yu, C., & Li, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178748 · Cited by 48
Konishi, K., Miyake, T., Furukawa, S., Senba, H., Kanzaki, S., Nakaguchi, H., Yukimoto, A., Nakamura, Y., Watanabe, T., Koizumi, Y., et al. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.02.026 · Cited by 46
Gentile, C. L., Weir, T., Cox‐York, K. A., Wei, Y., Wang, D., Reese, L., Moran, G., Estrada, A. L., Mulligan, C., Pagliassotti, M. J., et al. (2014) · Adipocyte · doi:10.4161/21623945.2014.978662 · Cited by 43
Cimini, F. A., Barchetta, I., Ciccarelli, G., Leonetti, F., Silecchia, G., Chiappetta, C., Cristofano, C. D., Capoccia, D., Bertoccini, L., Ceccarelli, V., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3358 · Cited by 40
Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis
Andrés‐Blasco, I., Herrero-Cervera, A., Vinué, Á., Martínez‐Hervás, S., Piqueras, L., Sanz, M., Burks, D. J., & Navarro, H. G. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0219 · Cited by 36
Han, M., Piorońska, W., Wang, S., Nwosu, Z. C., Sticht, C., Wang, S., Gao, Y. L., Ebert, M., Dooley, S., & Meyer, C. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2295-5 · Cited by 35
Akazawa, Y., & Nakao, K. (2016) · Hepatology Research · doi:10.1111/hepr.12658 · Cited by 30
Selvakumar, P. K. C., Kabbany, M. N., López, R., Tozzi, G., Alisi, A., Alkhouri, N., & Nobili, V. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2016.04.014 · Cited by 30
Gao, Y., Wang, Y., Liu, H., Liu, Z., & Zhao, J. (2020) · Digestive and Liver Disease · doi:10.1016/j.dld.2020.03.021 · Cited by 27
Afolabi, P. R., Scorletti, E., Smith, D. E., Almehmadi, A., Calder, P. C., & Byrne, C. D. (2018) · Journal of Breath Research · doi:10.1088/1752-7163/aacf12 · Cited by 26
Geng, Y., Wu, Z., Buist‐Homan, M., Blokzijl, H., & Moshage, H. J. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115183 · Cited by 24
Self-citationNon-alcoholic fatty liver disease: A risk factor for myocardial dysfunction?
Byrne, C. D., & Perseghin, G. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.12.002 · Cited by 11
The many faces of RIPK3: What about NASH?
Dara, L., & Kaplowitz, N. (2016) · Hepatology · doi:10.1002/hep.28700 · Cited by 7
Cited by
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Guo, J., Huang, X., Dou, L., Yan, M., Shen, T., Tang, W., & Li, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01251-0 · Cited by 1,718
Arroyave-Ospina, J. C., Wu, Z., Geng, Y., & Moshage, H. (2021) · Antioxidants · doi:10.3390/antiox10020174 · Cited by 527
Self-citationNAFLD: Mechanisms, Treatments, and Biomarkers
Nassir, F. (2022) · Biomolecules · doi:10.3390/biom12060824 · Cited by 405
Updated mechanisms of MASLD pathogenesis
Li, Y., Yang, P., Ye, J., Xu, Q., Wu, J., & Wang, Y. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02108-x · Cited by 300
The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease
Díaz, L. A., Arab, J. P., Louvet, A., Bataller, R., & Arrese, M. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00822-y · Cited by 207
Metadata
- Authors
- Geng, Y., Faber, K. N., de Meijer, V. E., Blokzijl, H., & Moshage, H.
- Venue
- Hepatology International
- Published
- 2021-02
- Volume
- 15
- Issue
- 1
- Pages
- 21-35
- ISSN
- 1936-0533 (ISSN-L)
- 1936-0541
- OpenAlex
- W3126209233
- Cited by
- 432
- References
- 112
- FWCI
- 36.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.